Hypodermic Needles Market Size | Global Research Report 2028
市场洞察
2021 年全球皮下注射针市场规模达 35.1953 亿美元,预计到 2028 年将达到 55.2928 亿美元,2021-2028 年期间的复合年增长率为 6.7%。
慢性病患病率的不断上升和疫苗需求的激增是推动市场增长的潜在参数,而替代品的可用性阻碍了全球皮下注射针头市场的扩张。
血液传播疾病的高发性、政府积极参与实施严格的法规、对注射药物和疫苗的需求不断增长以及新兴经济体尚未开发的潜力是推动安全针头市场增长的主要因素。主要市场参与者一直专注于产品发布和扩张等有机战略,同时也参与合作和伙伴关系等无机发展,以增强其区域主导地位。有机发展占战略增长的 60%,无机活动占组织总体发展的 40%。
从地区来看,北美占据全球注射针市场的大部分份额,并可能在整个预测期内保持主导地位。亚太地区可能在预测期内以最高的复合年增长率增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
全球注射针市场:
Global Hypodermic Needles Market: Strategic Insights
Global Hypodermic Needles Market
-
CAGR (2021 - 2028)
6.7%
-
Market Size 2021
US$ 3.52 Billion
-
Market Size 2028
US$ 5.53 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- EXELINT International Co
- Terumo Corporation
- BD
- B Braun Melsungen AG
- Catalent Inc
- Cardinal Health Inc
- Vita Needle Company
- Connecticut Hypodermics Inc
- Vygon
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
类型(安全针和非安全针)
应用(药物输送、疫苗接种、血液样本采集)
最终用户(诊断中心、医院和诊所以及家庭保健)
用途(一次性和可重复使用)
Global Hypodermic Needles Market: Strategic Insights
-
CAGR (2021 - 2028)6.7% -
Market Size 2021
US$ 3.52 Billion -
Market Size 2028
US$ 5.53 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- EXELINT International Co
- Terumo Corporation
- BD
- B Braun Melsungen AG
- Catalent Inc
- Cardinal Health Inc
- Vita Needle Company
- Connecticut Hypodermics Inc
- Vygon
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2021 - 2028 年)6.7%- 2021 年市场规模
35.2 亿美元 - 2028 年市场规模
55.3 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- EXELINT 国际公司
- 泰尔茂株式会社
- 屋宇署
- B. Braun Melsungen AG
- 康泰伦特公司
- 康德乐公司
- 维塔针业公司
- 康涅狄格州皮下注射公司
- 维贡
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 安全针和非安全针
- 药物输送
- 疫苗接种
- 血液样本采集
- 诊断中心
- 医院和诊所
- 家庭保健
- 一次性和可重复使用
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
COVID-19的影响
疫情期间对针头和注射器的巨大需求推动了全球注射针头市场的增长
全球 COVID-19 大流行导致住院人数增加,随后进行检查和用药,刺激了市场增长。COVID-19 疫苗接种的增加导致对针头和注射器的巨大需求。疫苗接种活动凸显了针头的效用。主要市场参与者利用这一机会来满足对一次性针头前所未有的需求。大流行需要快速开发疫苗来控制疾病。批准用于预防 COVID-19 的疫苗是使用皮下注射针头进行肌肉注射和皮下注射的。几家制造商维持了强大的供应链,以满足大流行期间持续接种疫苗的需求。
2021 年 1 月,BD 与美国卫生与公众服务部冠状病毒特别工作组密切合作,向美国各家医院分发了 8 亿支注射器和针头。由于意大利、德国、法国、西班牙和英国报告的 COVID 病例数量最多,欧洲的皮下注射针头市场出现大幅增长。2020 年 7 月,BD 收到英国政府 6500 万支针头和注射器的巨额订单,以支持该国的疫苗接种工作。在亚太地区,疫情对全球皮下注射针头市场造成了中等程度的打击。该地区的低收入国家面临医疗基础设施短缺和供应链中断的问题。然而,市场参与者专注于医疗发展,看到了对皮下注射针头的需求。三泽医疗工业开发了“低死腔针头”,可以减少注射器中剩余的药液量。
未来的趋势
皮下注射针设计的技术进步
制药行业已经见证了大量用于治疗多种慢性疾病的先进干预措施。人们越来越需要能够让患者或非临床医生安全注射药物的设备。无针喷射注射器是替代方案之一,但它相对昂贵,而且不太适合广泛分发。因此,整合先进技术使注射针更符合人体工程学变得至关重要。2020 年 8 月,麻省理工学院的科学家开发了一种原型注射针,其注射器包含两个针筒,针筒中装有粘稠药物和生物相容性润滑液。几家制造商正在研究精密设计的针头和针刺预防技术,以在具有挑战性的应用中脱颖而出。大多数公司都在提供安全的设计和更少疼痛的注射,以确保治疗成功。注射针正在接受受控制造和严格的检查,以确保质量。
驱动程序
慢性病患病率不断上升
糖尿病、心血管疾病、自身免疫性疾病和各种癌症等慢性疾病是导致死亡和残疾的主要原因。根据美国疾病控制和预防中心 (CDC) 的数据,2019 年美国约有十分之六的人患有至少一种慢性疾病。心血管疾病在世界各地导致高死亡率,估计每年有 1790 万人死亡。糖尿病是另一种危及生命的慢性疾病,目前尚无功能性治愈方法。外源性胰岛素通常通过皮下途径给予糖尿病患者。注射针被广泛用于胰岛素输送,能够实现自我给药和准确给药,这推动了注射针市场的发展。此外,大多数生物治疗药物都是使用注射针注射的,因为它们可以低成本、快速、直接地输送分子。
疫苗需求激增
根据世界卫生组织的数据,全球约 90% 的注射用于治疗。免疫注射约占 5%。疫苗需求的增加已成为全球皮下注射针头市场增长的关键因素。此外,普遍免疫计划 (UIP) 提供的可预防疾病的免疫覆盖率的提高也推动了市场的增长。联合国儿童基金会的共同努力使疫苗更安全、更容易获得。除此之外,COVID-19 疫苗的推出凸显了针头、注射器和其他免疫工具的关键作用。2020 年 7 月,史密斯医疗与美国政府合作,获得了 2000 万美元的投资,用于增加注射器和针头的产量,作为“曲速行动”疫苗计划的一部分。
限制
替代方案的可用性
针头注射的缺点众所周知。大量人口群体都存在对自我注射或针头恐惧症的心理抵触。在糖尿病管理方面,可穿戴注射器、笔式注射器和无针注射器等自我注射系统为患者提供了无与伦比的治疗控制权,从而限制了皮下注射针头市场的增长。微针的使用因其微创、缓解疼痛和抗感染等特点而受到青睐,最终抑制了相关市场的增长。此外,皮下注射针头市场正面临着无针注射器的激烈竞争,无针注射器技术先进,可注射高粘度药品。这些替代品对皮下注射针头的使用构成挑战,可能会阻碍市场增长。
市场细分
按类型
与传统注射器相比,其临床优势刺激了分部增长
全球皮下注射针市场按类型分为安全针和非安全针。前者在 2021 年占据了最大的市场份额,预计在预测期内将以最高的复合年增长率飙升。安全注射器具有内置安全机制,可降低针刺伤的风险。一些国家已经出台法规,以确保使用安全注射器并防止重复使用针头。这有助于加快安全注射器的使用,而不是传统注射器。提供安全针的主要参与者包括 BD 和 Cardinal Health。BD 制造主动和被动针头安全系统,Cardinal Health 提供 Monoject 和 Magellan 安全针头和注射器。
非安全针头成本低廉,使用得当,可提供无菌注射。分段式增长可归因于疫苗接种的常规使用以及发展中国家出生率的上升,需要更多的疫苗。BD 生产的通用皮下注射针头具有规则的斜面和壁,可提供格外顺畅的静脉进入,阻力最小。
按应用
慢性病和疫苗接种需求支撑该领域的主导地位
根据应用,全球皮下注射针市场细分为药物输送、疫苗接种和血液样本采集。药物输送细分市场在 2021 年占据市场主导地位,收入份额最大,预计在预测期内将录得最高复合年增长率。注射式药物输送系统为系统吸收提供了很大的表面积。细分市场的增长可以适应慢性病患病率的上升以及对疫苗、胰岛素、人类生长激素和现代药物的需求不断增长。此外,生物仿制药产品和低成本皮下注射针是药物输送的首选。几家公司正在对生物仿制药进行临床试验,这可能会在预测期内带来丰厚的机会。
疫苗接种领域是 2021 年第二大市场占有者,具有相当大的需求和增长潜力。疫苗接种每年可挽救数百万人的生命。世界各国政府都在大力投资以减轻全球疾病负担,特别是借助疫苗。疫苗接种通常被视为抵御可能导致医疗紧急情况的任何流行病的第一道防线。一些全球组织与地方政府合作,采取措施采购大量注射器和针头以开展疫苗接种。该细分市场的增长归因于不断增长的流行病潜力、对治疗性疫苗的重视以及新兴市场。
区域洞察
从地理上看,全球皮下注射针市场分为北美洲、欧洲、亚太地区 (APAC)、南美洲和中美洲 (SCAM) 以及中东和非洲 (MEA)。
2021 年,北美占据了最大的市场份额,预计到 2028 年仍将保持主导地位。该地区最高的市场占有率归因于献血量增加、传染病患病率上升、医院和临床实验室的高端基础设施、外科手术增加以及主要市场参与者的发展等方面。在美国,老年人口的增加容易患上各种疾病,癌症、糖尿病、慢性疼痛和胃肠道疾病的病例不断增加,可能会引发皮下注射针头市场的增长。癌症、糖尿病和自身免疫性疾病在加拿大越来越普遍。大约有 1100 万加拿大人患有糖尿病或糖尿病前期。该国患有 1 型糖尿病的人需要频繁注射胰岛素,从而增加了对注射器和皮下注射针头的需求。
亚太地区注射针市场在预测期内可能以最高的复合年增长率扩张。注射针的普及率不断提高、医疗保健基础设施不断发展、研发活动广泛开展以及癌症、心血管疾病和糖尿病的高发病率是推动市场增长的主要因素。在中国,市场增长主要由血液传播疾病、慢性疾病的日益流行以及对可行治疗方案的认识所推动。此外,该国的老年人群体可能会患上多种慢性疾病。印度注射针市场因慢性病和生活方式相关疾病的增多、老龄人口的不断增长以及人们对药物和医疗保健意识的不断提高而蓬勃发展。
注射针市场利润丰厚的地区
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
主要市场参与者:
- Exelint International, Co.(美国)
- 泰尔茂株式会社 (日本)
- BD(美国)
- B.Braun Melsungen AG(德国)
- Catalent Inc(美国)
- 康德乐公司 (美国)
- Vita Needle Company(美国)
- 康涅狄格州皮下注射公司 (美国)
- Vygon(法国)
- Nipro 公司 (日本)
- 谢菲尔德理发师(英国)
- Retractable Technologies, Inc.(美国)
- Air-Tite Products Co., Inc(美国)
皮下注射针市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 35.2亿美元 |
2028 年市场规模 | 55.3亿美元 |
全球复合年增长率(2021 - 2028) | 6.7% |
历史数据 | 2019-2020 |
预测期 | 2022-2028 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
主要进展:
2018 年 12 月:
Terumo 宣布在欧洲推出采用其 PLAJEX 预充注射器的生物仿制药。2021 年 10 月:
BD 在支持全球 COVID-19
疫苗接种工作中突破 20 亿注射装置的里程碑。2019 年 9 月:
B.Braun 和飞利浦推出了 Onvision 针尖追踪技术,这是区域麻醉实时超声引导领域的一次突破。
报告范围
全球皮下注射针市场研究报告提供了有关市场规模、份额、趋势和预测的详细见解。它提供了有关驱动因素、限制因素、机会、细分市场和行业格局的清晰而精确的专业知识。讨论了 COVID-19 的影响分析以及全球和区域市场随之而来的后果。一份关键市场参与者名单及其近年来各自的发展情况被特别提及。
Global Hypodermic Needles Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 3.52 Billion |
Market Size by | US$ 5.53 Billion |
Global CAGR | 6.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型(安全针和非安全针) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
New product launches, and acquisitions have helped the growth of market players across emerging regions.
The drug delivery segment is growing at the highest CAGR owing to increasing prevalence of chronic disease.
Various companies have made organic growth strategies in the hypodermic needles market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as BD, Cardinal Helath amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
The factors that are driving growth of the market are increasing chronic diseases prevalence, and surge in demand for vaccines.
The Asia Pacific is offering lucrative opportunities for market growth owing to large patient population and increasing immunization across the region.
The List of Companies - Hypodermic Needles Market
- EXELINT International, Co.
- Terumo Corporation
- BD
- B. Braun Melsungen AG
- Catalent Inc
- Cardinal Health Inc
- Vita Needle Company
- Connecticut Hypodermics Inc.
- Vygon
- Nipro
- Barber of Sheffield
- RETRACTABLE TECHNOLOGIES, INC.
- AIR-TITE PRODUCTS CO., INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.